Top 5 Leading Companies in PCR for Point-of-Care Diagnostics Market

According to BCC Research predictions, the global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% over the forecast period (2024 to 2029).

Driving factors for the forecast period are rising demand for point-of-care testing for infectious diseases (e.g., influenza A & B) and sexually transmitted diseases (HIV). Increasing adoption of multiplex testing to diagnose infectious diseases is an additional factor propelling the growth of the market.

Apart from this, in this blog, we will discuss the top leading companies associated with POC Diagnostics.

ABBOTT

Incorporated in 1888, Abbott Laboratories, a U.S.-based pharmaceutical and medical device manufacturing company, discovers, develops, manufactures and sells various healthcare products. The company operates business through four segments: Established Pharmaceutical Products, Diagnostics, Nutritional and Medical Devices.

The company offers point-of-care polymerase chain reaction analyzers (PCR) and associated consumables through the Diagnostic Products segment, whose subdivisions are Core Laboratories Diagnostics, Rapid Diagnostics, Molecular Diagnostics and Point of Care. The Rapid Diagnostics subsegment caters to the point-of-care PCR market.

DANAHER CORP.

Danaher Corp. designs and manufactures a wide range of products for various industries, including healthcare, environmental and industrial. Danaher operates in three segments: Life Sciences, Diagnostics and Biotechnology.

Danaher’s Diagnostics segment offers a broad range of diagnostic solutions, including clinical chemistry, immunoassays, hematology, microbiology, molecular diagnostics and POCT. Brands include Beckman Coulter, Cepheid, Leica Biosystems, Mammotome, HemoCue and Radiometer.

HOFFMANN-LA ROCHE LTD.
Hoffmann-La Roche Ltd. (Roche), a Switzerland-based healthcare company, primarily focuses on research discovery development and offers global customers diagnostic and therapeutic products and services. The company operates in two primary business segments: Pharmaceuticals and Diagnostics.

Roche offers a wide range of molecular diagnostic products, including point-of-care PCR systems and point-of-care PCR assays to detect respiratory infections. Roche is one of the major companies offering multiplex assays for influenza and respiratory syncytial virus.

THERMO FISHER SCIENTIFIC INC.

Thermo Fisher Scientific Inc. produces and markets instruments, reagents, software and services for the pharma and biotech, diagnostic and healthcare facilities, academic, industrial and applied sectors. The company has four business segments: life science solutions, laboratory products, biopharma services, analytical instruments and specialty diagnostics.

Mesa Biotech, a subsidiary of Thermo Fisher, created the Accula System, a cost-effective PCR-based testing platform designed to diagnose infectious diseases at the point of care. This system is praised for its rapid and precise testing capabilities, making it suitable for use in physician offices and pharmacies, with results available in just 30 minutes.

QIAGEN

QIAGEN specializes in molecular testing products and operates across two main segments: molecular diagnostics, catering to healthcare needs; and life sciences, serving academic research, as well as pharmaceutical and biotechnology companies. Its diverse product range includes consumable kits, instruments and bioinformatics tools.

QIAGEN currently maintains 35 subsidiaries across more than 25 countries, with a global workforce of 6,000 employees spread across more than 35 locations.

Learn More and Take Action:

Consider becoming a member of the BCC Research library and gain access to our full catalog of market research reports in your industry. Not seeing what you are looking for? We offer custom solutions too, including our new product line: Custom Intelligence Services.